72126-78-4,
UNII-F01WAX6X3P,
BRN 5365805,
F01WAX6X3P,
1,1-Ethenediamine,N,N'-bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-,
1,1-Ethenediamine, N,N'-bis(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-2-nitro-,
N,N'-Bis(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-2-nitro-1,1-ethenediamine,
N,N'-Bis(2-(((5-((dimethylamino)methyl)furan-2-yl)methyl)sulfanyl)ethyl)-2-nitroethene-1,1-diamine,
N,N'-Bis[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-2-nitro-1,1-ethenediamine,
AC1MHP2J,
Ranitidine impurity A (PhEur),
SCHEMBL11208703,
CTK5D5570,
DTXSID90222436,
ZINC8385570,
Ranitidine Related Compound B (USP),
AKOS030623083,
LS-67643,
FT-0667287,
Dimethylaminomethylfurylmethylthioethyl Ranitidine,
Dimethylaminomethylfurylmethylthioethyl Ranitidine [Ranitidine BP impurity A],
Ranitidine Related Compound B, United States Pharmacopeia (USP) Reference Standard,
1-N,1-N'-bis[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine,
1-N,1-N'-bis[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-2-nitroethene-1,1-diamine,
N,N inverted exclamation marka-Bis{2-{{{5-[(dimethylamino)methyl]furan-2-yl}methyl}sulfanyl}ethyl}-2-nitroethene-1,1-diamine,
N,N inverted exclamation marka-Bis{2-{{{5-[(dimethylamino)methyl]furan-2-yl}methyl}thio}ethyl}-2-nitro-1,1-ethylenediamine,
N,N'-Bis[2-[[[5-[(dimethylamino)methyl]furan-2-yl]-methyl]sulphanyl]ethyl]-2-nitroethene-1,1-diamine,
N,N'-Bis{2-{{{5-[(dimethylamino)methyl]furan-2-yl}methyl}sulfanyl}ethyl}-2-nitroethene-1,1-diamine, >=95.0% (HPLC), pharmaceutical impurity standard,
N,N-BIS{2-{{{5-[(DIMETHYLAMINO) METHYL]FURAN-2- YL}METHYL}SULFANYL}ETHYL}-2-NITROETHENE-1,1-DIAMINE (Ranitidine Related Compound B), (Ranitidine impurity A), Pharmaceutical Secondary Standard; Certified Reference Material,
Ranitidine Related Compound B,
C22H35N5O4S2,
C22-H35-N5-O4-S2,
CID3055214,